⌘K

Login Start Free

Home/Filings/4/0001127602-23-008443

4//SEC Filing

Garay Arpa 4

Accession 0001127602-23-008443

CIK 0001682852other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 5:27 PM ET

Size

7.4 KB

Accession

0001127602-23-008443

Insider Transaction Report

Form 4

Period: 2023-02-28

Moderna, Inc.MRNA

Chief Commercial Officer

Transactions

Award
Restricted Stock Units
2023-02-28+5,260→ 5,260 total
Exercise: $0.00→ Common Stock (5,260 underlying)
Award
Stock Option (Right to Buy)
2023-02-28+20,040→ 20,040 total
Exercise: $138.81From: 2024-02-28Exp: 2033-02-28→ Common Stock (20,040 underlying)

Footnotes (2)

[F1]25% of this option will vest and become exercisable on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F2]25% of the shares subject to this restricted stock unit award will vest on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Moderna, Inc.

CIK 0001682852

Entity typeother

Related Parties

1

filerCIK 0001916360

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 5:27 PM ET
Size: 7.4 KB

View on SEC.gov